What is a Registry and How Can it Help my Institution Generate Actionable Insights From our EHR Data? - Webinar Archives

| Share | Print
Thursday May 31, 2012 1:00 PM ET, 12:00 PM CT
Hospitals and integrated delivery systems are spending massive amounts of resources to implement complex electronic health record (EHR) systems, yet  many hospital administrators and clinical leaders are increasingly frustrated as they find that EHR systems don’t provide them the analytical tools they need to generate actionable insights from the rich data that is locked away in the EHR system.   ACOs and hospitals across the spectrum are scrambling to find tools that enable them to identify patterns in high-risk patient populations and clinical practice so they can make the adjustments necessary in light of Medicare payment reforms.
 
A growing number of researchers and institutions are turning to patient registries as a way to access and analyze patient data locked away in EHRs and other clinical information systems.  
 
Attendees of this educational webinar will learn the following:
  • What is a patient registry? How can it help generate actionable insights from clinical data?
  • How is a patient registry different than a data warehouse or a data mart? Why should I have a research data repository and an EDW?
  • What is a registry of patient registries and how can it benefit my institution? 
  • Why is cross-disease research and cross-specialty analytics important?
About the Speaker(s):

Dr. Michael Cummens
Remedy Informatics
CMO

Dr. Cummens has a wide range of experience as a physician and a bioinformaticist working in medical ontology development, medical informatics, and electronic health record development. Prior to joining Remedy, Dr. Cummens was the Associate Chief Medical Information Officer at Marshfield Clinic, a nationally recognized leader in quality health care delivery. He worked as an IT Consultant for EMR and clinical informatics at Silver Dragon Consulting from 2005¬-2008.  He served as Senior Director of Medical Informatics at Ascension Healthcare in St. Louis in 2005, and prior to that he was a Medical Informaticist at Intelligent Medical Objects in Northbrook, IL.
 
Dr. Cummens holds a medical degree from the University of Wisconsin and has more than twenty years of clinical experience in primary care. As a family practitioner he was an early adopter of clinical data management software; he built and implemented his own EMR system including a patient registry. Dr. Cummens is board certified in Family Medicine and is a member of the AAFP (American Academy of Family Physicians) and AMIA (American Medical Informatics Association).

Gary D. Kennedy
Remedy Informatics, Inc.
CEO

Gary is Remedy’s founder and chief visionary, defining the company’s strategic focus on translational research and groundbreaking research informatics products. Before launching Remedy, he served as President and Chief Executive Officer of TenFold, a software applications company. Gary served as President, Chief Executive Officer and Chairman of PRC, Inc., a systems integration company and wholly owned subsidiary of Black & Decker, Inc. Prior to joining PRC, Gary held a variety of management and executive positions at Oracle Corporation. His positions included National Sales Manager, Senior Vice-President of Oracle Corporation and President of Oracle USA.  He was one of the first twenty employees of Oracle.  Prior to joining Oracle he served as a Marketing Manager for Intel Corporation.
 
In addition to serving as Remedy’s CEO for the past eight years, Gary is the founder and managing partner of Double Eagle Ventures, a private venture fund targeting seed stage investments in the United States and Brazil. Previously, Gary was the first investor in TenFold Corporation. Gary holds a B.A. in finance from the University of Utah and a Masters in Business Administration from Northwestern University's Kellogg Graduate School of Management. He currently serves on the Board of Directors of several private companies and was named Utah Entrepreneur of the Year in 1999 by Ernst and Young.